ADC Therapeutics to Participate in February Investor Conferences
LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in two investor conferences in February. Details of the events are as follows:…
Details